CH386447A - Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure - Google Patents

Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure

Info

Publication number
CH386447A
CH386447A CH6639458A CH6639458A CH386447A CH 386447 A CH386447 A CH 386447A CH 6639458 A CH6639458 A CH 6639458A CH 6639458 A CH6639458 A CH 6639458A CH 386447 A CH386447 A CH 386447A
Authority
CH
Switzerland
Prior art keywords
substituted
aralkylamino
tertiary
alcohols
preparation
Prior art date
Application number
CH6639458A
Other languages
German (de)
English (en)
Inventor
Kralt Teunis
Durk Moed Hendrik
Johannes Asma Willem
Adolf Prof Lindner
Original Assignee
Philips Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Nv filed Critical Philips Nv
Publication of CH386447A publication Critical patent/CH386447A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH6639458A 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure CH386447A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL222701 1957-11-23

Publications (1)

Publication Number Publication Date
CH386447A true CH386447A (de) 1965-01-15

Family

ID=19751044

Family Applications (3)

Application Number Title Priority Date Filing Date
CH6639458A CH386447A (de) 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure
CH1310563A CH398629A (de) 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure
CH1310663A CH415663A (de) 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1310563A CH398629A (de) 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure
CH1310663A CH415663A (de) 1957-11-23 1958-11-20 Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure

Country Status (7)

Country Link
US (1) US3265577A (forum.php)
CH (3) CH386447A (forum.php)
DK (1) DK104630C (forum.php)
FR (1) FR1219254A (forum.php)
GB (1) GB914783A (forum.php)
NL (1) NL112650C (forum.php)
OA (1) OA00968A (forum.php)

Also Published As

Publication number Publication date
US3265577A (en) 1966-08-09
NL112650C (forum.php)
DK104630C (da) 1966-06-13
OA00968A (fr) 1968-08-07
GB914783A (en) 1963-01-02
FR1219254A (fr) 1960-05-17
CH398629A (de) 1966-03-15
CH415663A (de) 1966-06-30

Similar Documents

Publication Publication Date Title
CH354455A (de) Verfahren zur Herstellung von Thionophosphorsäureestern
CH382145A (de) Verfahren zur Herstellung neuer Thionothiolphosphinsäureestern
CH383374A (de) Verfahren zur Herstellung von Phosphonsäureestern
CH358429A (de) Verfahren zur Herstellung von Dialkyl-thiono-phosphorsäureestern von N-Methylolverbindungen
CH359440A (de) Verfahren zur Herstellung von Phosphonsäureestern
CH366037A (de) Verfahren zur Herstellung von Thiophosphorsäureestern
CH389583A (de) Verfahren zur Herstellung von B-Alkoxy-carbonsäureestern
CH336069A (de) Verfahren zur Herstellung neuer Ester von 5-Acyl-8-oxy-chinolinen
CH377796A (de) Verfahren zur Herstellung neuer Ester von substituierten sekundären oder tertiären Aralkyl-amino-alkoholen mit substituierter Benzoesäure
CH385840A (de) Verfahren zur Herstellung von Phosphonsäureestern
CH361274A (de) Verfahren zur Herstellung von Nitroalkylthiophosphorsäureestern
CH365718A (de) Verfahren zur Herstellung von basischen Estern
CH376916A (de) Verfahren zur Herstellung von Thionophosphonsäureestern
CH374080A (de) Verfahren zur Herstellung von Dithio-phosphorsäureestern
CH386447A (de) Verfahren zur Herstellung neuer Ester von substituierten, sekundären oder tertiären Aralkylamino-alkoholen mit substituierter Benzoesäure
CH371110A (de) Verfahren zur Herstellung von Acrylsäureestern
CH382158A (de) Verfahren zur Herstellung von Phosphonsäureestern
CH359146A (de) Verfahren zur Herstellung von Thiophosphorsäureestern
CH352999A (de) Verfahren zur Herstellung von a-Methyl-merkapto-thiol-phosphorsäureestern
CH353731A (de) Verfahren zur Herstellung von Estern
CH368156A (de) Verfahren zur Herstellung von Phosphorsäureestern
CH364249A (de) Verfahren zur Herstellung von Thionophosphorsäureestern
CH382140A (de) Verfahren zur Herstellung von Thiophosphorsäureestern
CH382148A (de) Verfahren zur Herstellung von Polyencarbonsäureestern
CH358091A (de) Verfahren zur Herstellung von Phosphorsäureestern